Active substance
Dipivefrin
- SFDA 1
- US FDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| OFTANEX 0.1% EYE DROPS | 0.1 % | Eye drops · Topical | 1 Dropper Container | SAR 28.55 | NCE · Prescription | BAYER SCHERING PHARMA | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PROPINE | 0.1% | solution/drops · ophthalmic | ALLERGAN | Discontinued | 2 May 1980 |
| DIPIVEFRIN HYDROCHLORIDE | 0.1% | solution/drops · ophthalmic | FALCON PHARMS | Discontinued | 30 Jun 1994 |
| DIPIVEFRIN HYDROCHLORIDE | 0.1% | solution/drops · ophthalmic | BAUSCH AND LOMB | Discontinued | 19 May 1995 |
| AKPRO | 0.1% | solution/drops · ophthalmic | EPIC PHARMA LLC | Discontinued | 29 Sep 1995 |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.